PTK2 and cancer: Our findings are in keeping with previous reports showing the importance of RhoA, Rac1 and Cdc42 in cancer progression [65], and also the crosstalk between these GTPases and other signaling pathways like Src-FAK in the migratory phenotype of cancer cells [66].